Oh yes I have. I might be off by a few million, but fairly close. Even if it was 40 million outstanding, it only effects the share price, not the capitalization value. Do I care about the share price, of course. But I care more that the company is a success for those suffering from such debilitating diseases and conditions they seek to alleviate. A company that has safely intracranially transplanted neural stem cells they created is not a scam. Yes they may fail in the long run, but not because they are a scam.
Market Data 
Markets 
AI
